Palliative Care Research
Online ISSN : 1880-5302
ISSN-L : 1880-5302
Original Research
Factors Related to Gemcitabine-induced Phlebitis
Akiko UnesokoAkio KohnoNobukazu TomitaKiyoshi IshigureAyumi SugimuraKazuki SatoShoko Ando
Author information
JOURNAL FREE ACCESS FULL-TEXT HTML

2018 Volume 13 Issue 2 Pages 187-193

Details
Abstract

Objective: The purpose of this study was to clarify the factors related to gemcitabine (GEM)-induced phlebitis. Methods: We retrospectively analyzed 400 cases of intravenous GEM administration to 50 patients from June 2014 to May 2015. We assessed the relationship between GEM-induced phlebitis and various factors including age, sex, BMI, analgesic use (NSAIDs or opioids), and GEM-administration procedures including drug formulation, dosage, and access site. Results: Phlebitis occurred in 79 cases (19.8%). Multivariate analysis indicated that sex (female), age (<65 years old), BMI (≥25 kg/m2; obesity), drug formulation (liquid), and access site (dorsal hand vein) were significantly related to the presence of phlebitis. Discussion: GEM-administration procedures should be modified in patients with these risk factors. It is desirable to apply hot fomentation and to puncture at the brachial region or cubital fossae region vein to prevent phlebitis.

Content from these authors
© 2018 by Japanese Society for Palliative Medicine
Previous article Next article
feedback
Top